Siddharth Mittal, Biocon CEO
A month after Biocon was handed a Form 483, documents reveal lackluster conditions
In September, Biocon got out in front of a Form 483 it was handed by the FDA in a rare out-of-the-country inspection, insisting that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
